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Training the Next Generation of Family Medicine Providers through Group 
Buprenorphine-Naloxone Visits 
 
Krystina Callahan, Lara Weinstein*, Erica Li, Sunny Lai, Alexis Silverio 
 
Introduction: The rise in opioid use disorders (OUD) and fatal overdoses highlight the 
need to expand access to and capacity for treating OUD. Medication Assisted Treatment 
(MAT), a medication/group visit model, done in the office setting, is an effective remedy 
for treating OUD. Understanding residents’ perspectives on their clinical training in MAT 
can inform the design of a more effective and responsive curriculum.  
Methods: A qualitative study using group semi-structured interviews with residents in an 
urban family medicine residency rotating through a federally qualified health center. 
Interviews centered on strengths and weaknesses of the MAT program, resident 
likeliness to prescribe MAT, and potential training that would boost confidence were 
conducted. Grounded theory was utilized to identify themes among transcripts.  
Results: Four interrelated themes emerged: modeling and mentorship, harm reduction, 
skills, and intent. Residents’ desire to treat and views on harm reduction, combined with 
their skills and mentorship, give them the confidence and intent to utilize MAT post-
residency. 
Discussion: Residents have the desire to prescribe MAT post-residency but lack 
confidence to do so. This can be attributed to a lack of modeling, mentorship, and skills 
developed within residency. Addition of this into programs, combined with exposure to 
harm-reduction as a principle and practice, must be incorporated into programs and could 
play an important role in closing the “treatment gap” by training the next generation of 
providers in providing MAT.   
 
 
